JRSM >
Volume 96, Number 6 >
Pp. 266-272
Eye and ENT Centre, University Hospital, Queen's Medical Centre, Nottingham NG7 2UH, UK
Correspondence to: Mr S A Vernon
 | SUMMARY |
|---|
 TOP SUMMARY INTRODUCTIONDIABETIC RETINOPATHYOTHER VITREO-RETINAL...NON-RETINAL OCULAR ABNORMALITIESREFERENCES |
|---|
| INTRODUCTION |
|---|
|
TOPSUMMARYINTRODUCTIONDIABETIC RETINOPATHYOTHER VITREO-RETINAL...NON-RETINAL OCULAR ABNORMALITIESREFERENCES |
|---|
Type 1 diabetes affects young lean people (usually diagnosed at <30 years); they are insulin deficient and always need insulin. Type 2 diabetes tends to affect older obese persons (>30 years but see above); the abnormality is partial insulin deficiency, insulin resistance or both. In both types, macrovascular disease leads to coronary artery disease, stroke and peripheral vascular disease while microvascular involvement causes nephropathy and retinopathy. Here we review the effects of diabetes on the eye, with an emphasis on the most important and characteristic—namely, diabetic retinopathy. Cataract apart, retinopathy is responsible for most of the sight-threatening complications of diabetes. However, ophthalmic practitioners, general physicians, general practitioners and optometrists should be aware of the various other diabetesassociated disorders so as to recognize them promptly and refer appropriately for treatment. The principal ophthalmic manifestations are summarized in Figure 1.
|
Despite over 20 years of laser therapy, diabetic retinopathy remains the leading cause of blindness in people of working age. 2 8% of those registered legally blind (vision < 3/60 in the better eye) have diabetes. A much larger number suffer ocular morbidity from retinopathy and are visually impaired or handicapped. Diabetics are twentynine times more likely to be blind than non-diabetics of a similar age. Retinopathy is the commonest complication of diabetes and up to 10% of diabetics at any one time will have sight-threatening retinopathy requiring specialist ophthalmological management. 3
| DIABETIC RETINOPATHY |
|---|
|
TOPSUMMARYINTRODUCTIONDIABETIC RETINOPATHYOTHER VITREO-RETINAL...NON-RETINAL OCULAR ABNORMALITIESREFERENCES |
|---|
The prevalence and severity of diabetic retinopathy increase with age and duration of diabetes. The condition is infrequent before the age of 13 years irrespective of the duration of diabetes. After diagnosis of diabetes, retinopathy is more frequent in the older-onset group. Indeed, 20% of type 2 diabetics have retinopathy at presentation, whereas those with type 1 diabetes can expect to be free of clinically significant retinopathy for the first 5 years. After 10-15 years, 25-50% of type 1 patients show some signs of retinopathy. This prevalence increases to 75-95% after 15 years and approaches 100% after 30 years. Proliferative disease is rare in the first decade from diagnosis but increases to 14-17% by 15 years and 50% after 25 years.
Of patients with type 2 diabetes, 23% have nonproliferative disease after 11-13 years, 41% after 14-16 years and 60% after 16 years. PDR can be found in 3% of patients 11 or more years after the diagnosis. Type 2 patients tend to develop maculopathy first, but many go on to develop proliferative retinopathy later. 7
Up to 10% of all patients with diabetes develop macular oedema during their lifetime and in nearly half of these the central fovea is affected. The likelihood depends upon the severity of retinopathy and the duration and type of diabetes. Only 3% of patients with mild non-proliferative disease have macular oedema, but the prevalence reaches 40% in those with moderate to severe disease and 70% in those with PDR.
Macular oedema is rare in patients with type 1 diabetes of less than 8 years' duration and the prevalence after 20 years is 25-30%. In type 2 patients receiving insulin the prevalence is 10% after 10 years and 30-35% after 20 years; in those not on insulin the prevalence is almost half the above.
The Diabetes Control and Complications Trial8 compared intensive glycaemic control with conventional insulin treatment in type 1 diabetes. Patients on the intensive regimen showed a lower incidence of retinopathy, less progression to preproliferative and proliferative retinopathy, less macular oedema and less need for panretinal photocoagulation. The UK Prospective Diabetes Study (UKPDS) showed similar advantages for intensive control in type 2 diabetes. 9 Data from various epidemiological studies suggest a positive relation between prevalence of retinopathy and hypertension. Increased blood pressure, through an effect on blood flow, has been hypothesized to damage the retinal capillary endothelial cells, resulting in development and progression of retinopathy. The UKPDS showed that beta-blockers and angiotensin converting enzyme inhibitors were equally effective in reducing the risk of progression of retinopathy in newly diagnosed persons with type 2 diabetes. Data from most studies suggest an association between the prevalence of diabetic nephropathy, as manifest by microalbuminuria or gross proteinuria, and retinopathy. 10 Although smoking causes tissue hypoxia by increasing blood carbon monoxide levels and can promote platelet aggregation, most epidemiological data show no relation between cigarette smoking and diabetic retinopathy. Pregnancy is a significant predictor of progression of diabetic retinopathy, and women with type 1 diabetes who get severe retinopathy in pregnancy are at excess risk of giving birth to a child with congenital abnormalities. 11
Physical activity, socioeconomic status, body mass index and consumption of alcohol are some of the other risk factors with a bearing on the incidence and progression of diabetic retinopathy.
Clinical features (see Figures 2,3,4,5)
The clinical signs of diabetic retinopathy are divided into background,
preproliferative and proliferative stages
(Table 1).
|
|
|
|
|
Background diabetic retinopathy (mild non-proliferative diabetic retinopathy)
Early circulatory changes Retinal vasodilation, one of the
earliest findings in diabetic retinopathy, possibly results from the loss of
capillary pericytes and thickening of the capillary basement membrane.
12
Microaneurysms Retinal microaneurysms are usually the first sign of diabetic retinopathy and are located within the inner nuclear layer in capillaries linking the superficial and deep capillary network. They range in diameter from 12 to 100 µm but only those greater than 30 µm in diameter can be seen ophthalmoscopically.
Intraretinal haemorrhages Ruptured microaneurysms, capillaries and venules are all sources of intraretinal haemorrhages, which are mostly located within the outer plexiform and inner nuclear layers. Deep haemorrhages are dots and blots while superficial ones in the nerve fibre layer are flame-shaped. A predominance of flame-shaped haemorrhages points to the presence of concomitant venous obstruction or arterial hypertension.
Hard exudates These are extracellular collections of lipid within the outer plexiform layer, derived from leakage of serum from the abnormal vessels. They are yellowish and vary in size. They may be confluent or arranged in a circinate pattern around a cluster of microvascular abnormalities. Scattered hard exudates often come and go, but continued focal leakage will result in plaques that can cause permanent functional impairment if located on the fovea.
Cotton-wool spots (soft exudates) Cotton-wool spots result from focal abnormalities of axoplasmic transport in the nerve fibre layer from localized capillary ischaemia and appear as superficial, white, fluffy edged patches. Large numbers of them may signify the presence of arterial hypertension.
Preproliferative diabetic retinopathy (moderate and severe non-proliferative diabetic retinopathy)
This is the intermediate stage between background and proliferative
retinopathy. Signs of increasing ischaemia develop, including arterial
thinning and occlusion (seen as white lines in the retina) or more commonly,
venous beading and looping, and intraretinal microvascular abnormalities.
Proliferative diabetic retinopathy
Neovascularization originating from the disc, retina or iris is the
hallmark of proliferative retinopathy. New vessels can grow across the surface
of the retina or on the posterior vitreous face, when they may be associated
with fibrous tissue seen as gliotic bundles. Neovascular fronds can result in
preretinal or vitreous haemorrhages. Preretinal haemorrhage is seen as
localised boat-shaped haemorrhage between the posterior hyaloid face and the
internal limiting membrane of the retina. In the presence of a detached
vitreous (as occurs in many elderly people) subsequent new vessel growth is
limited to focal raspberry-like lesions without fibrosis. Small haemorrhages
into the vitreous cause ‘floaters’, whereas more extensive
vitreous haemorrhage can cause sudden and painless loss of vision. Advanced
proliferative disease is characterized by fibrovascular proliferation and
contraction that can lead to continued vitreous haemorrhage and tractional
retinal detachment. Rubeosis iridis (see below) and secondary glaucoma
complete the picture of advanced disease.
Although sometimes unilateral, proliferative diabetic retinopathy nearly always becomes bilateral in due course. 13
| OTHER VITREO-RETINAL ABNORMALITIES |
|---|
|
TOPSUMMARYINTRODUCTIONDIABETIC RETINOPATHYOTHER VITREO-RETINAL...NON-RETINAL OCULAR ABNORMALITIESREFERENCES |
|---|
| NON-RETINAL OCULAR ABNORMALITIES |
|---|
|
TOPSUMMARYINTRODUCTIONDIABETIC RETINOPATHYOTHER VITREO-RETINAL...NON-RETINAL OCULAR ABNORMALITIESREFERENCES |
|---|
Cornea
Corneal sensitivity is commonly impaired in diabetes, and is inversely
related to the severity of retinopathy.
14 This sensory
deficit may predispose to bacterial corneal ulcers, neurotropic ulcers and
difficulties with contact lenses; indeed, diabetic patients who wear contact
lenses must take extra care with lens hygiene and be warned to seek advice
early if trouble develops. Intrinsic abnormalities of the epithelial basement
membrane complexes, with impaired barrier function, lead to superficial
punctate keratitis and poor healing after trauma and the formation of
persistent epithelial defects.
15 Epithelial
defects and recurrent corneal erosions can develop after photocoagulation and
vitrectomy. 16 The
treatment in most cases is topical lubricants; in some cases bandage contact
lenses are required.
Glaucoma
Primary open-angle glaucoma
Diabetic patients have higher intraocular pressures than the normal
population, especially those treated with insulin,
17 but evidence of
an association between primary open-angle glaucoma and diabetes is
conflicting. Case-control studies show relative risks of 1.6 to 4.7 in
diabetes.
18,19
The Baltimore Eye Survey found little evidence of an association between
glaucoma and diabetes,
20 whereas the Blue
Mountains study was more positive. Two important considerations regarding
intraocular pressure in diabetes are as follows: first, the patients are at
excess risk of visual field loss and this happens at relatively low
pressures;21
second, use of topical beta-blockers (e.g. timolol maleate) to lower the
pressure can mask hypoglycaemic symptoms and reduce glucose tolerance.
Narrow-angle glaucoma
Patients with narrow-angle glaucoma are more likely to have abnormal
glucose tolerance than either those with primary open-angle glaucoma or
healthy controls, and there is an excess prevalence of type 2
diabetes.22 This
seems to be a consequence of the abnormally large lens in diabetes. Also, in
hyperglycaemia the lens can swell rapidly, precipitating angle-closure
glaucoma. In diabetic patients glycerol should not be used as hyperosmotic
agent during an acute attack since it is metabolized to glucose.
Iris neovascularization (rubeosis iridis) (Figure 6)
Proliferative diabetic retinopathy remains a leading cause of neovascular
glaucoma, second only to central retinal vein occlusion. Profound retinal
ischaemia seems to stimulate production of vascular endothelial growth factor,
which diffuses into the anterior segment of the eye and causes
neovascularization of the iris. Early neovascularization appears as small
tufts of blood vessels along the pupillary margin or in the anterior chamber
angle. It may cause glaucoma even without secondary closure, through exudation
of plasma proteins into the aqueous.
|
The treatment of established neovascular glaucoma is difficult. Usually, extensive panretinal photocoagulation is required to induce neovascular regression. This may be accomplished by conventional laser, vitrectomy with endo-laser, or retinal treatment through the sclera by diode laser/cryotherapy. Filtering glaucoma surgery with antimetabolite (5-fluorouracil or mitomycin-C) enhancement or the insertion of drainage tubes into the eye can sometimes control the intraocular pressure. Diode laser cyclophotocoagulation, to reduce aqueous production, is gaining popularity.23
Pupil abnormalities
Some diabetic patients have small pupils in dim illumination which dilate
poorly to mydriatic agents. The cause is an autonomic neuropathy partially
denervating both the sphincter and the dilator muscles.
Lens
Refractive error
Fluctuating myopia can be a presenting sign in diabetes. Collection of the
sugar alcohol sorbitol in the lens, due to increased aldose reductase
activity, causes the lens to swell and change its refractive power. In newly
diagnosed diabetes and when therapy is changed, patients should be advised not
to get new spectacles until the blood glucose has stabilized.
Cataract formation
Data from the Framingham and other eye studies indicate a three to fourfold
increased prevalence of cataract in patients with diabetes under 65, and up to
a twofold excess prevalence in patients above
65.24,25
The risk is increased with the duration of diabetes and in those with poor
metabolic control. A special type of cataract known as snowflake cataract is
seen in young type 1 patients and tends to progress rapidly. Cataracts may be
reversible in young diabetics with improvement in metabolic control.
The most frequently seen type of cataract in diabetics is the age-related or ‘senile’ variety, which tends to occur earlier and progresses more rapidly than in nondiabetics. Common early symptoms are frequent changes of spectacles, glare and dazzle, and monocular diplopia or polyopia (double or multiple images in one eye).
Cataract surgery in diabetics
There has been a recent shift in emphasis towards earlier cataract
extraction in diabetics. Pre-existing macular oedema is the major risk factor
for poor visual outcome after cataract
surgery,26 but the
surgery may cause a rapid acceleration of retinopathy and induce
rubeosis.27
Cataract surgery is advisable before lens opacity precludes detailed fundus
examination, and pre-existing maculopathy should be adequately treated with
focal laser beforehand.
Phacomulsification results in less postoperative inflammation and astigmatism, more rapid visual rehabilitation and, with modern foldable lenses, a lower incidence of capsulotomy than with the outdated extracapsular surgery, and is now the preferred technique in most types of cataract. However, no difference in retinopathy progression between the two techniques has been reported.28
Cystoid macular oedema is a sight-threatening complication occurring after cataract surgery and is related to postoperative inflammation. Diabetics with or without evidence of diabetic retinopathy demonstrate a compromised blood aqueous barrier leading to an increased risk of postoperative inflammation. Other factors influencing the amount of postoperative inflammation and incidence of clinical and angiographic cystoid macular oedema (Figure 7) are duration of surgery, wound size and posterior capsular rupture or vitreous loss.
|
Careful postoperative follow-up is essential after cataract surgery not only to check for development of cystoid macular oedema but also to make sure there has been no acceleration of diabetic retinopathy. Regarding the operation itself, the continuous curvilinear capsulorrhexis technique performed in most phacoemulsification cases provides many advantages over previous capsulotomy techniques. One disadvantage is anterior capsular contraction29 and opacification that can hamper adequate retinal evaluation and retinal laser treatment.
Optic nerve abnormalities
Acute disc oedema
Acute disc oedema (diabetic papillopathy) affects patients in their second
to fourth decades. It is often bilateral and usually causes no
symptoms.30 On
routine ophthalmoscopic examination it is characterized by diffuse oedema or
severe disc swelling with soft exudates, cystoid macular oedema and
occasionally macular star formation. There is no correlation with the severity
of diabetic retinopathy but individuals require close observation since rapid
progression to proliferative retinopathy may ensue. Distinction of this
condition from papilloedema is important.
Optic atrophy (Wolfram's syndrome)
Wolfram's syndrome is a complication of diabetes mellitus associated with
progressive optic atrophy and multiple other neurological and systemic
abnormalities. Patients show neurosensory hearing loss and some also have
diabetes insipidus, anosmia and gonadal
dysfunction.31 It
is autosomal recessive or sporadic in inheritance.
Non-arteritic ischaemic optic neuropathy
This condition causes acute visual loss in older patients with diabetes and
must be distinguished from the arteritic variety, in which the optic disc
appearance is similar with pale swelling (sometimes sectoral). Pointers to the
arteritic type are a history of typical symptoms of inflammatory vasculopathy
and the finding of tender thickened temporal arteries.
Optic atrophy
The causes of optic atrophy in diabetic patients include previous diabetic
papillopathy, previous non-arteritic ischaemic optic neuropathy, multiple
nerve fibre layer infarcts and extensive pan-retinal
photocoagulation.32
Visual field abnormality
Common reasons for a visual field abnormality in diabetes are
cerebrovascular accident, coexisting glaucoma and pan-retinal
photocoagulation. All patients undergoing pan-retinal photocoagulation must be
warned about the potential for significant visual field loss. Small-burn laser
therapy with increased burn numbers minimizes the effect on the binocular
driving visual field test demanded by the Driver and Vehicle Licensing
Authority.33
Macular laser treatment, delivered in a grid fashion, does not significantly
affect the DVLA field
test.34
Other cranial nerve abnormalities
In 25-30% patients above the age of 45 years with acute extraocular muscle
palsy, diabetes is the underlying cause. Isolated third, fourth and sixth
nerve palsies are due to small vessel occlusion. Third nerve palsies may be
painful in up to 20% cases and the pupil is spared in 80%. If the pupil is
involved (20%), the effect is usually subtle with an anisocoria of <1 mm
rather than the fully dilated unreactive pupil found in compressive
lesions.35 Most
patients recover after weeks or months but the condition may recur.
Simultaneous involvement of two or more nerves is rare and so is the presence
of other focal neurological signs, progressive deterioration or lack of
complete recovery in three months. The presence of any of the above,or a palsy
at age <45 years should be investigated to exclude a compressive
lesion.
| REFERENCES |
|---|
|
TOPSUMMARYINTRODUCTIONDIABETIC RETINOPATHYOTHER VITREO-RETINAL...NON-RETINAL OCULAR ABNORMALITIESREFERENCES |
|---|
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
